Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

Unfortunately we've had to endure overly cautious PRs as of late. We got snacked back on that speculative buy by Mackie Research. It was a BS 60 cent US target and Cad regulators jumped all over it. No momentum there. Now that we see how the market has thus far reacted to the news, I'm wondering if management should have just taken the hit for missing another deadline for data? This trial was due to already be over. So we push into 2021 and the PR doesn't nail down a timeline. How much longer do they want to stretch this out... January, February, March?

We're suppose to get data for Chronic Cough in Q1 2021. Anybody confident we'll get it on time? Something is seriously wrong with this picture. We always get the short n sh!tty end of the stick no matter what these guys do. Good news is bad news and bad news is worse. Meanwhile, the number one individual shareholder (5+%) of Algernon continues to pump the hell out of the sister company based on the same retread beta news year over year (2015 - 2020...). What proven formula is that that's not being passed down or allowed by management at Algernon? It's not adding up, never has added up for longs here. Another lump of Coal for Christmas @ Algernon Pharmaceuticals Inc.

Just crazy stuff,

M$

P.S. No need for every blue moon troll to opine.

Outro

I No Longer Have Any Idea Who The F*** Algernon Be